July 11, 2020

The Niche

Knoepfler lab stem cell blog

Fred Upton

4 min read

It can be kind of a big deal when politicians, especially at the federal level, write the FDA about stem cells. Is this going to be good news or bad? Some combination? I tend to worry that some senators or representatives might pressure the FDA to weaken oversight. However, lately it seems like the opposite is happening. Perhaps pressure the other direction, for less oversight, doesn’t see the light of day. Last April Senator Grassley wrote the FDA about problematic stem cell clinics and …Read More